Gavi, the Vaccine Alliance, and its partners today celebrate a major breakthrough in girls’ health in Nigeria.
In just two weeks, an impressive 7 million girls have been vaccinated against the human papillomavirus (HPV), a critical step in protecting them from cervical cancer later in life.
Gavi’s commitment to girls’ health
This achievement marks a significant milestone in Nigeria’s fight against cervical cancer.
In October 2023, Gavi partnered with the Nigerian Ministry of Health and Social Welfare, the National Primary Health Care Development Agency, WHO, and UNICEF to introduce the HPV vaccine into the national immunization program.
Building on this success, Gavi further expanded its collaboration with Girl Effect in May 2024 to focus on reaching girls with critical information and ensuring vaccine access.
Protecting a generation from cervical cancer
Cervical cancer is the second most prevalent cancer among women in Nigeria, claiming countless lives each year.
The HPV vaccine offers a highly effective tool for prevention, with an average success rate of 92%. By vaccinating 7 million girls in just two weeks, Nigeria has made significant progress towards its goal of reaching 16 million girls by 2025.
Dr. Sani Nishtar, CEO of Gavi, stated:
“This achievement is a testament to the tremendous collaboration between Gavi, the Nigerian government, and our partners. By prioritising girls’ health, we are empowering a generation and helping to save countless lives.”
Image
Global impact
Globally, cervical cancer is responsible for over 342,000 deaths annually, with a disproportionate impact on women in low- and middle-income countries.
Ensuring broad access to the HPV vaccine is critical to reducing this devastating disease burden.
